Application of a macrocyclization strategy in kinase inhibitor development
Kinases have a pivotal role in phosphorylation and kinase dysregulation has been implicated in the occurrence and progression of various diseases. By mid-2024 the Food and Drug Administration had approved 81 small-molecule kinase inhibitors targeting greater than 30 kinases, providing substantial cl...
Saved in:
Main Authors: | Kun Xing, Shujun Li, Jinghuan Li, Dan Liu, Min Huang, Linxiang Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Compuscript Ltd
2025-01-01
|
Series: | Acta Materia Medica |
Online Access: | https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2024-0070 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Application of Calixarenes as Macrocyclic Ligands for Uranium(VI): A Review
by: Katarzyna Kiegiel, et al.
Published: (2013-01-01) -
A membrane permeability database for nonpeptidic macrocycles
by: Qiushi Feng, et al.
Published: (2025-01-01) -
Hydrogen-bonded macrocycle-mediated dimerization for orthogonal supramolecular polymerization
by: Wentao Yu, et al.
Published: (2025-01-01) -
Densely populated macrocyclic dicobalt sites in ladder polymers for low-overpotential oxygen reduction catalysis
by: Zhen Zhang, et al.
Published: (2025-01-01) -
Janus kinase inhibitors and biologics for treatment of livedoid vasculopathy: a systematic review
by: Yu Liu, et al.
Published: (2025-12-01)